Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | MAOB | P27338 | 9/20 | 0.52 |
| ▸ | MAOA | P21397 | 7/20 | 0.52 |
| ▸ | KDM1A | O60341 | 5/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.52 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.52 |
| ▸ | HTR2C | P28335 | 3/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | HTR1A | P08908 | 1/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11904658 | 1.00 | MEN1 (0.65) | MEN1KMT2AMAOBMAOAKDM1A | |
| Cyclohexane SCHEMBL7567386 | 0.88 | MEN1 (0.60) | MEN1KMT2ASLC6A2S1PR1ALDH1A1 | |
| SCHEMBL2768025 | 0.88 | MAOB (0.57) | MEN1KMT2AMAOBMAOAKDM1A | |
| SCHEMBL2768026 | 0.88 | MAOB (0.57) | MEN1KMT2AMAOBMAOAKDM1A | |
| SCHEMBL2769401 | 0.88 | MAOB (0.57) | MEN1KMT2AMAOBMAOAKDM1A | |
| Ammonia Solution, Strong SCHEMBL11529212 | 0.85 | MAOB (0.55) | MEN1KMT2AMAOBMAOAKDM1A | |
| Bicarbonate SCHEMBL7569185 | 0.85 | MEN1 (0.57) | MEN1KMT2AMAOBMAOAKDM1A | |
| SCHEMBL3869911 | 0.83 | SLC18A3 (0.59) | MEN1KMT2ACYP1A2CYP2D6CYP2C9 | |
| SCHEMBL10494836 | 0.83 | MAOB (0.60) | MEN1KMT2AMAOBMAOAKDM1A | |
| SCHEMBL13479566 | 0.83 | MAOB (0.60) | MEN1KMT2AMAOBMAOAKDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 467 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4581071-A1 | METHOD FOR PRODUCING A MATERIAL FOR A MEMBRANE, MATERIAL, MEMBRANE AND USE OF A MEMBRANE | Forschungszentrum Jülich GmbH (DE) | 2025-07-09 | — | — | EP | claimed |
| WO-2024046712-A1 | METHOD FOR PRODUCING A MATERIAL FOR A MEMBRANE, MATERIAL, MEMBRANE AND USE OF A MEMBRANE | Forschungszentrum Jülich GmbH (DE) | 2024-03-07 | — | — | WO | claimed |
| EP-0207241-B1 | FABRIC INK RIBBON | Pelikan Aktiengesellschaft (DE) | 1991-04-10 | — | — | EP | claimed |
| US-RE33113-E | Pressure sensitive recording paper | FUJI PHOTO FILM CO., LTD. (JP) | 1989-11-14 | — | — | US | claimed |
| US-4773778-A | Fabric printer ribbon comprising a liquid vehicle containing a decolorizable Lewis acid/Lewis base complex | PELIKAN AKTIENGESELLSCHAFT (DE) | 1988-09-27 | — | — | US | claimed |
| EP-0207241-A1 | Fabric ink ribbon | Pelikan Aktiengesellschaft (DE) | 1987-01-07 | — | — | EP | claimed |
| EP-0031708-B1 | CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES THEREFOR | ICI PHARMA (FR) | 1984-06-13 | — | — | EP | claimed |
| EP-0075434-A2 | Cephalosporins, their preparation and their pharmaceutical compositions | ICI PHARMA (FR) | 1983-03-30 | — | — | EP | claimed |
| EP-0071370-A2 | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them | ICI PHARMA (FR) | 1983-02-09 | — | — | EP | claimed |
| EP-0031708-A2 | Cephalosporin derivatives, processes for their manufacture, pharmaceutical compositions containing them and intermediates therefor | ICI PHARMA (FR) | 1981-07-08 | — | — | EP | claimed |
| US-4154697-A | Liquid crystalline hexahydroterphenyl derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1979-05-15 | — | — | US | claimed |
| US-3981821-A | CONDENSATION POLYMERIZATION, AMINO RESINS POLYEPOXIDES | FUJI PHOTO FILM CO., LTD. (JA) | 1976-09-21 | — | — | US | claimed |
| US-20260005300-A1 | SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK AND ELECTRICAL DEVICE CONTAINING THE SAME | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2026-01-01 | — | — | US | disclosed |
| US-20250266502-A1 | LITHIUM-ION BATTERY ELECTROLYTIC SOLUTION, LITHIUM-ION BATTERY, AND METHOD FOR IMPROVING BATTERY PERFORMANCE | Guangzhou Tinci Materials Technology Co., Ltd (CN) | 2025-08-21 | — | — | US | disclosed |
| EP-4581071-A1 | METHOD FOR PRODUCING A MATERIAL FOR A MEMBRANE, MATERIAL, MEMBRANE AND USE OF A MEMBRANE | Forschungszentrum Jülich GmbH (DE) | 2025-07-09 | — | — | EP | disclosed |
| EP-3306732-B1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR BATTERIES AND LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS INC (JP) | 2025-06-25 | — | — | EP | disclosed |
| US-4154697-A | Liquid crystalline hexahydroterphenyl derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1979-05-15 | — | — | US | disclosed |
| US-4154697-A | Liquid crystalline hexahydroterphenyl derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1979-05-15 | — | — | US | disclosed |
| US-4124526-A | Encapsulation process and resulting aqueous dispersion of encapsulated droplets | MONSANTO COMPANY (US) | 1978-11-07 | — | — | US | disclosed |
| US-3981821-A | CONDENSATION POLYMERIZATION, AMINO RESINS POLYEPOXIDES | FUJI PHOTO FILM CO., LTD. (JA) | 1976-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260005300-A1 | SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK AND ELECTRICAL DEVICE CONTAINING THE SAME | LBR, SCO2, HCN2 | MEN1 874/4885KMT2A 2419/4885MAOB 399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.